Table 3.
Baseline clinical demographics within the Society for Cardiovascular Magnetic Resonance Registry.
| Parameter | Value | Number of exams | |
|---|---|---|---|
| Demographics | 154,458 | ||
| Age, years | 58 (43-69) | 154,407 | |
| Sex, n (% male) | 82,205 (56%) | 145,275 | |
| Race, n (%) | White/Caucasian | 69,766 (72%) | 98,008 |
| Black/AA | 17,789 (18%) | ||
| Asian | 2391 (2%) | ||
| Hispanic/Latino | 1977 (2%) | ||
| Other | 6085 (6%) | ||
| Field strength | 1.5T | 100,294 (74%) | 135,610 |
| 3T | 35,316 (26%) | ||
| Medical history | |||
| Hypertension n (%) | 51,403 (58%) | 88,198 | |
| Hyperlipidemia n (%) | 40,993 (47%) | 88,088 | |
| Diabetes n (%) | 17,847 (23%) | 87,906 | |
| Coronary artery disease n (%) | 13,076 (21%) | 62,953 | |
| Moderate-to-severe valve disease n (%) | 15,399 (18%) | 85,550 | |
| Heart failure n (%) | 16,508 (19%) | 86,884 | |
| Tobacco use (prior or current) n (%) | 25,444 (30%) | 84,813 | |
| Family history of CAD n (%) | 25,041 (30%) | 87,614 | |
| Peripheral arterial disease n (%) | 1511 (3%) | 54,084 | |
| Congenital heart disease n (%) | 9028 (10%) | 87,258 | |
| Non-ischemic cardiomyopathy n (%) | 7051 (9%) | 86,749 | |
| Cardiomyopathy subtype n (%) | Amyloid | 142 (3%) | 5553 |
| ARVC | 72 (1%) | ||
| HCM | 1492 (27%) | ||
| Idiopathic DCM | 1097 (20%) | ||
| Sarcoid | 184 (3%) | ||
| Other | 764 (14%) | ||
| Unknown | 1802 (32%) | ||
| History of pacemaker or ICD | ICD | 1339 (46%) | 2900 |
| Pacemaker | 1270 (44%) | ||
| ILR | 291 (10%) | ||
| Rhythm | |||
| Sinus rhythm | 67,799 (83%) | 81,357 | |
| Atrial fibrillation/flutter | 5072 (6%) | ||
| Frequent ectopy | 7846 (10%) | ||
| Paced rhythm | 640 (1%) | ||
| Medications | |||
| Aspirin | 37,682 (44%) | 85,641 | |
| Angiotensin-converting enzyme inhibitor | 21,077 (24%) | 87,821 | |
| Angiotensin receptor blocker | 13,299 (16%) | 83,119 | |
| Beta blocker | 37,310 (43%) | 86,767 | |
| Nitrate | 6512 (8%) | 81,400 | |
| Diuretic | 24,586 (29%) | 84,799 | |
| Statin | 36,766 (43%) | 85,502 | |
| Contrast agent classification | 123,594 | ||
| Linear (type I) | 50,674 (41%) | ||
| Macrocyclic (type II) | 72,920 (59%) | ||
| Vital signs | |||
| Body surface area (kg/m2) | 1.97 (1.78-2.15) | 134,655 | |
| Systolic blood pressure (mmHg) | 129 (117-143) | 109,211 | |
| Diastolic blood pressure (mmHg) | 74 (66-90) | 109,183 | |
| Heart rate (bpm) | 72 (63-83) | 120,117 | |
| Labs | |||
| Creatinine (ng/dL) | 0.95 (0.80-1.17) | 88,267 | |
| eGFR | 79 (64-98) | 74,059 | |
| Outcomes | |||
| Mortality | Alive | 123,017 (92%) | 132,979 |
| Dead | 9962 (8%) | ||
Data are presented as mean ± SD or median (IQR) or frequency (%) as appropriate. AA African American, ARVC arrhythmogenic right ventricular cardiomyopathy, CAD coronary artery disease, DCM dilated cardiomyopathy, eGFR estimated glomerular filtration rate, HCM hypertrophic cardiomyopathy, ICD implantable cardioverter defibrillator, ILR implantable loop recorder.